| 36639288 | Surgical Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricular Assist Device Implantation: Interim analysis of the TVVAD trial. | J Thorac Cardiovasc Surg | 2024 |
| 37757995 | Medical Therapy Before, During and After Hospitalization in Medicare Beneficiaries With Heart Failure and Diabetes: Get With The Guidelines - Heart Failure Registry. | J Card Fail | 2024 |
| 38065238 | Metabolomic profiling during ex situ normothermic perfusion before heart transplantation defines patterns of substrate utilization and correlates with markers of allograft injury. | J Heart Lung Transplant | 2024 |
| 38032571 | Donor Heart Recovery and Preservation Modalities in 2024. | JACC Heart Fail | 2024 |
| 34856337 | Trends in cardiovascular medicine: Update on cardiac transplantation. | Trends Cardiovasc Med | 2023 |
| 37666729 | Potential Applicability of Omecamtiv Mecarbil to Patients Hospitalized for Worsening Heart Failure. | Am J Cardiol | 2023 |
| 37527176 | When you need to dive in the deep end-Transplanting SARS-CoV-2 PCR+ recipients. | Transpl Infect Dis | 2023 |
| 37556894 | Incidence and Predictors of Relapse After Weaning Immune Suppressive Therapy in Cardiac Sarcoidosis. | Am J Cardiol | 2023 |
| 37659618 | LMNA Cardiomyopathy: Important Considerations for the Heart Failure Clinician. | J Card Fail | 2023 |
| 37586950 | The Role of Recipient Thyroid Hormone Supplementation in Primary Graft Dysfunction After Heart Transplantation: A Propensity-Adjusted Analysis. | J Cardiothorac Vasc Anesth | 2023 |
| 37479053 | The Promise and Risks of mHealth in Heart Failure Care. | J Card Fail | 2023 |
| 37510791 | Patient Perspectives on Digital Interventions to Manage Heart Failure Medications: The VITAL-HF Pilot. | J Clin Med | 2023 |
| 37829247 | Real-world Experiences in the Transplantation of Hepatitis C-NAAT-positive Organs. | Transplant Direct | 2023 |
| 37929577 | Longitudinal Trends in Donor and Recipient Risk Profile, and Clinical Outcomes, for Donation After Circulatory Death Heart Transplantation. | Circ Heart Fail | 2023 |
| 37495281 | A Global Challenge and a Global Opportunity for the Heart Failure Community. | J Am Coll Cardiol | 2023 |
| 37192288 | Use of a Cardiac Scale to Predict Heart Failure Events: Design of SCALE-HF 1. | Circ Heart Fail | 2023 |
| 37192287 | Echocardiographic Features Beyond Ejection Fraction and Associated Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction. | Circ Heart Fail | 2023 |
| 36958390 | Beyond Stage C: Considerations in the Management of Patients With Heart Failure Progression and Gaps in Evidence. | J Card Fail | 2023 |
| 37425440 | Variation among organ procurement organizations in experience and practice of heart donation after circulatory death. | JTCVS Open | 2023 |
| 37392192 | Multicenter study of universal prophylaxis versus pre-emptive therapy for patients at intermediate risk (R+) for CMV following heart transplantation. | Clin Transplant | 2023 |
| 37352965 | Variation in Hemodynamic Assessment and Interpretation: A Call to Standardize the Right Heart Catheterization. | J Card Fail | 2023 |
| 37422145 | Expanding the donor pool to improve outcomes for adults with complex congenital heart disease. | J Heart Lung Transplant | 2023 |
| 37318420 | Opportunities and Achievement of Medication Initiation Among Inpatients With Heart Failure With Reduced Ejection Fraction. | JACC Heart Fail | 2023 |
| 37285526 | Transplantation Outcomes with Donor Hearts after Circulatory Death. | N Engl J Med | 2023 |
| 37212192 | Contemporary Use of Sodium-Glucose Cotransporter-2 Inhibitor Therapy Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in the US: The Get With The Guidelines-Heart Failure Registry. | JAMA Cardiol | 2023 |
| 37074702 | Quality of Care and Clinical Outcomes for Patients With Heart Failure at Hospitals Caring for a High Proportion of Black Adults: Get With The Guidelines-Heart Failure Registry. | JAMA Cardiol | 2023 |
| 37439224 | Dual-Organ Transplantation: Indications, Evaluation, and Outcomes for Heart-Kidney and Heart-Liver Transplantation: A Scientific Statement From the American Heart Association. | Circulation | 2023 |
| 37464579 | Patients hospitalized with acute heart failure, worsening renal function, and persistent congestion are at high risk for adverse outcomes despite current medical therapy. | Clin Cardiol | 2023 |
| 37401479 | Inhaled Epoprostenol Compared With Nitric Oxide for Right Ventricular Support After Major Cardiac Surgery. | Circulation | 2023 |
| 37400049 | Transthyretin amyloid cardiomyopathy among patients hospitalized for heart failure and performance of an adapted wild-type ATTR-CM machine learning model: Findings from GWTG-HF. | Am Heart J | 2023 |
| 36965688 | Is it Time to Personalize Digital Health Interventions? | J Card Fail | 2023 |
| 37431671 | Patterns of Referral and Postdischarge Utilization of Cardiac Rehabilitation Among Patients Hospitalized With Heart Failure: An Analysis From the GWTG-HF Registry. | Circ Heart Fail | 2023 |
| 37363857 | Health care resource utilization and clinical outcomes for adult heart transplant recipients with primary graft dysfunction. | Clin Transplant | 2023 |
| 37227388 | Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk. | JACC Heart Fail | 2023 |
| 36965001 | The association with organ procurement techniques and early cardiac transplant outcomes using cardiac MRI. | Clin Transplant | 2023 |
| 36516937 | The Association Between Beta-blocker and Renin-Angiotensin System Inhibitor Use After Heart Failure With Reduced Ejection Fraction Hospitalization and Outcomes in Older Patients. | J Card Fail | 2023 |
| 36806447 | Quality of Care and Outcomes Among Patients Hospitalized for Heart Failure in Rural vs Urban US Hospitals: The Get With The Guidelines-Heart Failure Registry. | JAMA Cardiol | 2023 |
| 36536991 | Mechanisms of current therapeutic strategies for heart failure: more questions than answers? | Cardiovasc Res | 2023 |
| 36681212 | Management of Heart Failure With Reduced Ejection Fraction. | Curr Probl Cardiol | 2023 |
| 36754528 | Applicability of Vericiguat to Patients Hospitalized for Heart Failure in the United States. | JACC Heart Fail | 2023 |
| 36314130 | In-Hospital Virtual Peer-to-Peer Consultation to Increase Guideline-Directed Medical Therapy for Heart Failure: A Pilot Randomized Trial. | Circ Heart Fail | 2023 |
| 36369983 | Fit for the future: empowering clinical trials with digital technology. | Eur Heart J | 2023 |
| 36351494 | Improved Outcomes in Severe Primary Graft Dysfunction After Heart Transplantation Following Donation After Circulatory Death Compared With Donation After Brain Death. | J Card Fail | 2023 |
| 34797576 | Association of tacrolimus time-to-therapeutic range on renal dysfunction and acute cellular rejection after orthotopic heart transplantation in a high use basiliximab population. | Clin Transplant | 2022 |
| 35403023 | Donation after circulatory death heart transplantation in the United States: An early report of donor characteristics. | JTCVS Tech | 2022 |
| 35462033 | Health System-Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: Results From the CONNECT-HF Trial. | J Card Fail | 2022 |
| 35789019 | Improving implementation of evidence-based therapies for heart failure. | Clin Cardiol | 2022 |
| 35722989 | Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HF. | J Am Heart Assoc | 2022 |
| 35483801 | Reply: Revisited Metformin Therapy in Heart Failure With Preserved Ejection Fraction. | JACC Heart Fail | 2022 |
| 35447338 | Donation After Circulatory Death in Heart Transplantation: History, Outcomes, Clinical Challenges, and Opportunities to Expand the Donor Pool. | J Card Fail | 2022 |